Also referred to as PSUR.
EMA required pharmacovigilance document prepared by the marketing authorisation holder to provide an up to date evaluation of the benefit-risk-balance of a medicine. PSURs describe the worldwide safety experience with a medicine at a defined time after its authorization. Summarized data on the benefit-risk of a medicine and results of all studies of the medicine, authorised and unauthorised uses, are included.
« Back to Glossary Index